Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

UBS Maintains Neutral on Xometry, Lowers Price Target to $21

Author: Benzinga Newsdesk | March 13, 2024 12:45pm
UBS analyst Karl Keirstead maintains Xometry (NASDAQ:XMTR) with a Neutral and lowers the price target from $22 to $21.

Posted In: XMTR

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist